360 High-Risk Vulnerability Immunization Tool V2.0 vs Iru Endpoint: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Iru Endpoint: Unified endpoint mgmt, EDR, and vuln mgmt platform for cross-platform devices. built by Iru. Core capabilities include Cross-platform device management for Mac, Windows, and Android, Single lightweight agent with automatic updates, Endpoint detection and response with AI-powered threat protection..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Iru Endpoint differentiates with Cross-platform device management for Mac, Windows, and Android, Single lightweight agent with automatic updates, Endpoint detection and response with AI-powered threat protection.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Iru Endpoint is developed by Iru. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.

360 High-Risk Vulnerability Immunization Tool V2.0 and Iru Endpoint serve similar Endpoint Protection Platform use cases: both cover Patch Management. Review the feature comparison above to determine which fits your requirements.